Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May 14:10:1114-20.
doi: 10.3762/bjoc.10.110. eCollection 2014.

Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid

Affiliations

Stereocontrolled synthesis of 5-azaspiro[2.3]hexane derivatives as conformationally "frozen" analogues of L-glutamic acid

Beatrice Bechi et al. Beilstein J Org Chem. .

Abstract

Several strategies aimed to "freeze" natural amino acids into more constrained analogues have been developed with the aim of enhancing in vitro potency/selectivity and, more in general, drugability properties. The case of L-glutamic acid (L-Glu, 1) is of particular importance since it is the primary excitatory neurotransmitter in the mammalian central nervous system (CNS) and plays a critical role in a wide range of disorders like schizophrenia, depression, neurodegenerative diseases such as Parkinson's and Alzheimer's and in the identification of new potent and selective ligands of ionotropic and metabotropic glutamate receptors (GluRs). To this aim, bicycle compound Ib was designed and synthesised from D-serine as novel [2.3]-spiro analogue of L-Glu. This frozen amino acid derivative was designed to further limit the rotation around the C3-C4 bond present in the azetidine derivative Ia by incorporating an appropriate spiro moiety. The cyclopropyl moiety was introduced by a diastereoselective rhodium catalyzed cyclopropanation reaction.

Keywords: Amino acids; carbenes; cyclopropanation; rhodium; spiro compounds.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Glutamate receptor ligands.
Scheme 1
Scheme 1
Proposed synthetic plan for the preparation of compound of type Ib.
Scheme 2
Scheme 2
Synthesis of 3-azetidinone derivative 16.
Scheme 3
Scheme 3
Synthetic routes to prepare target cyclopropyl derivatives 20. Reagents and conditions: a) (EtO)2POCH2COOEt, NaH, THF, 0 °C, −78 °C, rt, 2 h 30 min, 68%; b) i. methyltriphenylphosphonium bromide, n-BuLi, THF, −78 °C to rt, 2 h 30 min, 23%; ii. Tebbe reagent 0.5 M in toluene, Pyr, THF, −40 °C to rt, 36%; iii. Petasis reagent, toluene, 70–90 °C in the dark, 2 h, 58%; iv. trimethylsilylsulfoxonium iodide, DBU, MeCN, 60 °C, 6 h; v. Et2Zn, CH2I2, DCM, 0 °C to rt, 5 days; vi. ethyl diazoacetate, Rh2(OAc)4 10 mol %, DCM, 40 °C, 48 h, 60%. vii. TEA.3HF, TEA, THF, 50 °C, 24 h, 92%; viii. TEA.3HF, TEA, THF, 50 °C, 24 h, 92% then DIBAL, DCM, −78 °C to rt, 12 h, 27%.
Figure 2
Figure 2
Mechanism for the attack of the carbene intermediate to the olefin moiety 18.
Figure 3
Figure 3
Representation of the lowest energy conformation of each diastereoisomers.
Scheme 4
Scheme 4
Synthesis of glutamate “frozen” analogues 4-carboxy-1-(ethoxycarbonyl)-5-azaspiro[2.3]hexane.

Similar articles

References

    1. Danbolt N C. Prog Neurobiol. 2001;65:1. doi: 10.1016/S0301-0082(00)00067-8. - DOI - PubMed
    1. Wroblewski J T, Danysz W. Annu Rev Pharmacol Toxicol. 1989;29:441. doi: 10.1146/annurev.pa.29.040189.002301. - DOI - PubMed
    1. Parsons C G, Danysz W, Quack G. Drug News Perspect. 1998;11:523. doi: 10.1358/dnp.1998.11.9.863689. - DOI - PubMed
    1. Meldrum B, editor. Excitatory Amino Acid Antagonists. Oxford, England: Blackwell; 1991.
    1. Collingridge G L, Watkins J C, editors. The NMDA Receptor. 2nd ed. Oxford, England: IRL Press; 1994.

LinkOut - more resources